El Salvador HIV AIDS Industry Outlook 2022 - 2026

See how El Salvador HIV AIDS performed compared to key markets such as Swaziland, Cape Verde and Latvia.

Key Market Indicators

HIV/AIDS treatment coverage in El Salvador is set to reach 66 percent of those living with HIV by 2026, up from 57 percent in 2021. This growth amounts to a 2.3-point year-on-year increase since 2006. El Salvador ranked 89th in 2021, while Tajikistan topped the list at 57 percent. Cape Verde, Latvia and Zimbabwe came in 2nd, 3rd and 4th respectively. The prevalence of HIV/AIDS among those aged 0-14 in El Salvador is projected to reach 534 people in 2026, unchanged from 2021. This is a decrease of 0.1 percent year-on-year since 1995. El Salvador ranked 75th in 2021, with Bangladesh surpassing it at 534 people. Nigeria, Mozambique and Tanzania took the 2nd, 3rd and 4th spots respectively.

El Salvador HIV AIDS Market Data and Forecasts

How much will El Salvador HIV AIDS Market grow to 2026?

Forecast: Incidence of Tuberculosis (Including HIV-Positive Cases) in El Salvador
Forecast: Incidence of HIV Among People Aged 15-24 in El Salvador

Other Top Countries about HIV AIDS